279 reports of this reaction
2.0% of all TRANEXAMIC ACID reports
#8 most reported adverse reaction
HAEMORRHAGE is the #8 most commonly reported adverse reaction for TRANEXAMIC ACID, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 279 FDA adverse event reports linking TRANEXAMIC ACID to HAEMORRHAGE. This represents approximately 2.0% of all 13,960 adverse event reports for this drug.
Patients taking TRANEXAMIC ACID who experience haemorrhage should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HAEMORRHAGE is a less commonly reported adverse event for TRANEXAMIC ACID, but still significant enough to appear in the safety profile.
In addition to haemorrhage, the following adverse reactions have been reported for TRANEXAMIC ACID:
The following drugs have also been linked to haemorrhage in FDA adverse event reports:
HAEMORRHAGE has been reported as an adverse event in 279 FDA reports for TRANEXAMIC ACID. This does not prove causation, but indicates an association observed in post-market surveillance data.
HAEMORRHAGE accounts for approximately 2.0% of all adverse event reports for TRANEXAMIC ACID, making it a notable side effect.
If you experience haemorrhage while taking TRANEXAMIC ACID, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.